SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (322)4/1/1999 4:58:00 PM
From: scaram(o)uche  Respond to of 3158
 
OK..... $0.40 plus the lease plus any small compensation for the milestones plus residual cash, and we ought to make it to about $0.40.

:-)

I'm not going to go back and dig it out, but..... seems as though this is headed toward the (from memory) $2.25 that was predicted earlier in the thread.

Thanks to those who outlined the op!! My cost was 1.72 on 2/18.



To: Biomaven who wrote (322)4/9/1999 11:49:00 AM
From: aknahow  Read Replies (1) | Respond to of 3158
 
IBD article on 8 April. By 2002 20 of top 25 selling drugs will be marketed by U.S. companies. based on analysis by U.K. company Evaluate. European companies will sell just three by 2002.

Was not going to bother to post this but I think this will be an additional spur to European companies to do deals, both partnerships and mergers, asap.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News